Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

1 mg finasteride can cause reversible painful breast enlargement in men.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Phospholipid soft vesicles improve topical drug delivery for better skin condition treatments.

The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Low estrogen and high testosterone may cause excessive hair growth in women.

Finasteride delivery through skin improved using invasomes and iontophoresis.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Low-dose oral minoxidil is effective and safe for treating hair loss in men and women.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Low-dose oral minoxidil improved or stabilized hair loss in some patients, but higher doses may be needed for significant effects.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

17-β-Estradiol applied to the skin stops hair growth, while ICI 182 780 helps hair grow in mice.

Combining hyaluronic acid and oxygen may help improve urinary incontinence in menopausal women.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Low-dose oral minoxidil is being revisited as a promising hair loss treatment.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Hormonal imbalances in women can cause acne, excess hair growth, and hair loss, needing combined medical and mental health care.